Nathan R. McGee

443 total citations
18 papers, 297 citations indexed

About

Nathan R. McGee is a scholar working on Neurology, Rheumatology and Genetics. According to data from OpenAlex, Nathan R. McGee has authored 18 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 7 papers in Rheumatology and 5 papers in Genetics. Recurrent topics in Nathan R. McGee's work include Autoimmune Neurological Disorders and Treatments (11 papers), Glycogen Storage Diseases and Myoclonus (7 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Nathan R. McGee is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (11 papers), Glycogen Storage Diseases and Myoclonus (7 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Nathan R. McGee collaborates with scholars based in United States, Slovakia and Canada. Nathan R. McGee's co-authors include Michael R. Pranzatelli, Elizabeth D. Tate, Jerry A. Colliver, Edward W. Tate, Richard M. Ransohoff, Anna L. Travelstead, Jayne Ness, Steven J. Verhulst, E A Roberts and Simon King and has published in prestigious journals such as Journal of the Neurological Sciences, Journal of Neuroinflammation and Journal of Neuroimmunology.

In The Last Decade

Nathan R. McGee

18 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan R. McGee United States 11 194 64 61 55 51 18 297
Can Ebru Bekircan‐Kurt Türkiye 10 103 0.5× 27 0.4× 44 0.7× 19 0.3× 73 1.4× 39 233
Chloé Bost France 12 233 1.2× 63 1.0× 12 0.2× 64 1.2× 67 1.3× 29 405
Swantje Mindorf Germany 6 152 0.8× 18 0.3× 23 0.4× 19 0.3× 48 0.9× 7 323
Frederik Bartels Germany 11 128 0.7× 28 0.4× 31 0.5× 11 0.2× 29 0.6× 18 249
Ario Mirian Canada 7 219 1.1× 39 0.6× 29 0.5× 14 0.3× 44 0.9× 17 253
Martin Köhnlein Germany 7 179 0.9× 16 0.3× 18 0.3× 39 0.7× 41 0.8× 9 292
Vincent Damotte United States 8 88 0.5× 40 0.6× 22 0.4× 34 0.6× 66 1.3× 12 369
Vyanka Redenbaugh United States 10 185 1.0× 60 0.9× 14 0.2× 20 0.4× 36 0.7× 24 263
Shunsuke Yoshimura Japan 8 120 0.6× 56 0.9× 13 0.2× 10 0.2× 58 1.1× 37 252
Claudio Mazia Argentina 6 604 3.1× 36 0.6× 18 0.3× 48 0.9× 91 1.8× 17 680

Countries citing papers authored by Nathan R. McGee

Since Specialization
Citations

This map shows the geographic impact of Nathan R. McGee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan R. McGee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan R. McGee more than expected).

Fields of papers citing papers by Nathan R. McGee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan R. McGee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan R. McGee. The network helps show where Nathan R. McGee may publish in the future.

Co-authorship network of co-authors of Nathan R. McGee

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan R. McGee. A scholar is included among the top collaborators of Nathan R. McGee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan R. McGee. Nathan R. McGee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, & Craig A. MacArthur. (2018). Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome. Pediatric Neurology. 85. 71–75. 6 indexed citations
2.
Pranzatelli, Michael R., Tyler Allison, Nathan R. McGee, & E. Tate. (2018). Cerebrospinal fluid γδ T cell frequency is age-related: a case–control study of 435 children with inflammatory and non-inflammatory neurological disorders. Clinical & Experimental Immunology. 193(1). 103–112. 4 indexed citations
3.
Pranzatelli, Michael R., Nathan R. McGee, & Elizabeth D. Tate. (2018). Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS. Journal of Neuroimmunology. 321. 150–156. 9 indexed citations
4.
Pranzatelli, Michael R., Elizabeth D. Tate, & Nathan R. McGee. (2018). Multifactorial analysis of opsoclonus‐myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children. Pediatric Blood & Cancer. 65(8). e27097–e27097. 15 indexed citations
5.
Pranzatelli, Michael R., Elizabeth D. Tate, & Nathan R. McGee. (2017). Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges. Journal of the Neurological Sciences. 381. 285–290. 13 indexed citations
6.
Pranzatelli, Michael R., Edward W. Tate, & Nathan R. McGee. (2017). Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study. Frontiers in Neurology. 8. 468–468. 56 indexed citations
7.
Pranzatelli, Michael R. & Nathan R. McGee. (2017). Neuroimmunology of OMS and ANNA-1/anti-Hu paraneoplastic syndromes in a child with neuroblastoma. Neurology Neuroimmunology & Neuroinflammation. 5(2). e433–e433. 8 indexed citations
8.
Pranzatelli, Michael R., et al.. (2016). Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus. Neurology Neuroimmunology & Neuroinflammation. 4(2). e316–e316. 4 indexed citations
9.
Tate, Elizabeth D., Nathan R. McGee, & Michael R. Pranzatelli. (2014). Clinical and Demographic Features of 389 Children with OMS: an International Cohort. 4 indexed citations
10.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, et al.. (2013). BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. Journal of Neuroinflammation. 10(1). 10–10. 37 indexed citations
11.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, & Jerry A. Colliver. (2013). Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders. Journal of the Neurological Sciences. 326(1-2). 53–58. 10 indexed citations
12.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, & Richard M. Ransohoff. (2013). CCR7 signaling in pediatric opsoclonus–myoclonus: Upregulated serum CCL21 expression is steroid-responsive. Cytokine. 64(1). 331–336. 10 indexed citations
13.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, & Steven J. Verhulst. (2013). CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders. Journal of Neuroimmunology. 266(1-2). 75–81. 26 indexed citations
14.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, & Jerry A. Colliver. (2013). Pediatric Reference Ranges for Proinflammatory and Anti-Inflammatory Cytokines in Cerebrospinal Fluid and Serum by Multiplexed Immunoassay. Journal of Interferon & Cytokine Research. 33(9). 523–528. 24 indexed citations
15.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, Jerry A. Colliver, & Richard M. Ransohoff. (2013). CCR4 Agonists CCL22 and CCL17 are Elevated in Pediatric OMS Sera: Rapid and Selective Down-Regulation of CCL22 by ACTH or Corticosteroids. Journal of Clinical Immunology. 33(4). 817–825. 10 indexed citations
16.
Pranzatelli, Michael R., E. Tate, Nathan R. McGee, et al.. (2013). Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus–myoclonus syndrome. Clinical & Experimental Immunology. 172(3). 427–436. 15 indexed citations
17.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, et al.. (2012). Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS. Journal of Neuroimmunology. 243(1-2). 81–88. 32 indexed citations
18.
Roberts, E A, Simon King, Margaret Fearon, & Nathan R. McGee. (1998). Hepatitis C in children after transfusion: assessment by look-back studies.. PubMed. 61(2). 195–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Can Ebru Bekircan‐Kurt Breakdown of academic impact, for papers by Chloé Bost Breakdown of academic impact, for papers by Swantje Mindorf Breakdown of academic impact, for papers by Frederik Bartels Breakdown of academic impact, for papers by Ario Mirian Breakdown of academic impact, for papers by Martin Köhnlein Breakdown of academic impact, for papers by Vincent Damotte Breakdown of academic impact, for papers by Vyanka Redenbaugh Breakdown of academic impact, for papers by Shunsuke Yoshimura Breakdown of academic impact, for papers by Claudio Mazia
Rankless by CCL
2026